. 2012 Sep 27;141(8):1625–1639. doi: 10.1017/S0950268812002166

Table 5 a.

Median values of multipliers and incidence rates per country and per pathogen

Country …		DE	DK	IT^*	NL	PL	SE	UK	Median
Campylobacter	Multiplier	9·3^a	29^b	100^b	49^b	72^c	17^b	52^a	—
	Population	620^a	2200^b	2300^b	2000^b	2000^c	1400^b	5000^a	2200
	GP	220^a	430^b	870^b	220^a	617^c	220^a	830^a	430
	Hospital	14^a	12^a	14^b	11^a	50^c	11^b	24^a	14
Salmonella	Multiplier^†	6·7^a	17^b	17^b	20^b	18^c	10^b	40^a	—
	Population^‡	520^a	620^b	290^b	340^b	633^c	440^b	1100^a	520
	GP^‡	180^a	160^b	100^b	47^b	189^c	100^b	200^a	160
	Hospital^‡	25^a	8·4^a	16^b	5·5^a	58^c	6·2^b	5·2^a	8·4
Yersinia	Multiplier	13^b	20^b	—	46^b	71^c	13·6^b	2200^b	—
	Population	100^b	93^b	—	120^b	406^c	110^b	110^b	110
	GP	37^b	25^b	—	18^a	154^c	24^b	20^a	24
	Hospital	3·9^b	0·5^a	—	0·2^c	2·4^b	1·4^b	0·1^d	1·0
Shigella	Multiplier	11^a	30^b	—	53^b	65^c	18^b	61^a	—
	Population	15^a	82^b	—	110^b	10^c	94^b	150^a	88
	GP	5·3^a	18^b	—	14^b	3^c	17^b	25^a	17
	Hospital	0·4^a	0·7^a	—	0·3^a	0·4^b	0·8^b	0·4^a	0·45
STEC	Multiplier	23^b	33^d	—	87^b	—	13^b	34^b	—
	Population	2·2^b	85^d	—	76^b	—	15^b	50^b	50
	GP	1·1^b	37^d	—	19^b	—	5·1^c	6·8^b	6·8
	Hospital	0·2^b	0·9^b	—	0·3^b	—	1·6^b	3·1^b	0·9
EPEC	Multiplier	34^b	100^c	—	—	—	—	—	—
	Population	140^b	870^c	—	—	—	—	—	505
	GP	48^b	200^c	—	—	—	—	—	124
	Hospital	4·8^b	5·0^b	—	—	—	—	—	4·9
Cryptosporidium	Multiplier	100^c	—	—	2100^b	—	—	93^b	—
	Population	130^c	—	—	4000^b	—	—	770^b	770
	GP	43^c	—	—	330^b	—	—	130^b	130
	Hospital	1·6^c	—	—	0·8^c	—	—	0·2^b	0·8

DE, Germany; DK, Denmark; IT, Italy; NL, The Netherlands; PL, Poland; SE, Sweden; UK, United Kingdom.

GP, General Practitioner; STEC, Shiga toxin-producing E. coli O157; EPEC enteropathogenic Escherichia coli.

Data from three provinces in Italy.

^†

CV (coefficient of variation = standard deviation/mean): ^a CV < 0·25, ^b 0·25 ⩽ CV < 1·0, ^c 1·0 ⩽ CV < 4·0, ^d CV ⩾ 4·0.

^‡

Incidence rate/100 000 person-years.